Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Authors:
- Hsi-Wen YehHYHsi-Wen Yeh
- Nicole Lauren DelGaudioNDNicole Lauren DelGaudio
- Beste UygurBUBeste Uygur
- Alon MilletAMAlon Millet
- Artem KhanAKArtem Khan
- Gokhan UnluGUGokhan Unlu
- Michael XiaoMXMichael Xiao
- Rebecca C. TimsonRTRebecca C. Timson
- Caifan LiCLCaifan Li
- Kerem OzcanKOKerem Ozcan
- Karl W. SmithKSKarl W. Smith
- Luiza Martins Nascentes MeloLMLuiza Martins Nascentes Melo
- 31 July 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 15 (12) , 2437-2449
Abstract
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression. Significance: Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.Keywords
All Related Versions
Funding Information
- Center for Cancer Research (1R01CA273233-01, 5U54CA261701)
- American Association for Cancer Research (22-40-01-YEH)
- Division of Diabetes, Endocrinology, and Metabolic Diseases (F99DK144923)
- Damon Runyon Cancer Research Foundation (DRG-2431-21)
- Mark Foundation For Cancer Research (Emerging Leader Award)
- Deutsche Forschungsgemeinschaft (467788900)
- Bundesministerium für Forschung, Technologie und Raumfahrt (161L0271)
- Center for Cancer Research (1K99CA286722-01)
This publication has 71 references indexed in Scilit:
- Solute carriers: The gatekeepers of metabolismCell, 2025
- In-vivo tracking of deuterium metabolism in mouse organs using LC-MS/MSJournal of Chromatography A, 2024
- Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial MetabolismCell, 2016
- ROS-dependent signal transductionCurrent Opinion in Cell Biology, 2015
- Extracellular Metabolic Energetics Can Promote Cancer ProgressionCell, 2015
- A Mitochondrial Switch Promotes Tumor MetastasisCell Reports, 2014
- Nuclear glutathioneBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Targeted Expression of Catalase to Mitochondria Prevents Age-Associated Reductions in Mitochondrial Function and Insulin ResistanceCell Metabolism, 2010
- A Translational Profiling Approach for the Molecular Characterization of CNS Cell TypesCell, 2008
- Knockout of the Mouse Glutamate Cysteine Ligase Catalytic Subunit (Gclc) Gene: Embryonic Lethal When Homozygous, and Proposed Model for Moderate Glutathione Deficiency When HeterozygousBiochemical and Biophysical Research Communications, 2000